SORA

Advancing, promoting and sharing knowledge of health through excellence in teaching, clinical practice and research into the prevention and treatment of illness

Current and emerging drug therapies for the treatment of depression in adults with epilepsy.

Mula, M; Sander, JW (2018) Current and emerging drug therapies for the treatment of depression in adults with epilepsy. Expert Opin Pharmacother, 20 (1). pp. 41-45. ISSN 1744-7666 https://doi.org/10.1080/14656566.2018.1543402
SGUL Authors: Mula, Marco

[img] Microsoft Word (.docx) Accepted Version
Available under License ["licenses_description_publisher" not defined].

Download (51kB)

Abstract

INTRODUCTION: Depression is the most frequent psychiatric comorbidity among people with epilepsy. It can impact on quality of life and increases the risk of morbidity and premature mortality. Areas covered: The authors review the available data on current and emerging drug treatments for depression in epilepsy. Sources have been identified through Medline/PubMed searches while ongoing clinical trials have been identified through a ClinicalTrials.gov search. Expert opinion: SSRIs are the drug class with the largest amount of data. Though promising, the level of evidence provided by these studies is still low as the majority have relevant methodological limitations. Antiepileptic drugs under development have the unique opportunity to be of multi-use in the treatment of epilepsy and depression. The serotoninergic system has already been identified as a potential area of interest, but new targets are still needed in epilepsy and depression. For this reason, it is important that basic scientists working on these two conditions develop collaborative projects and integrate findings.

Item Type: Article
Additional Information: This is an Accepted Manuscript of an article published by Taylor & Francis in Expert Opinion on Pharmacotherapy on 14/11/2018, available online: http://www.tandfonline.com/10.1080/14656566.2018.1543402.
Keywords: Epilepsy, SSRIs, antidepressant drugs, antiepileptic drugs, depression, 1115 Pharmacology And Pharmaceutical Sciences, Pharmacology & Pharmacy
SGUL Research Institute / Research Centre: Academic Structure > Institute of Medical & Biomedical Education (IMBE)
Academic Structure > Institute of Medical & Biomedical Education (IMBE) > Centre for Clinical Education (INMECE )
Journal or Publication Title: Expert Opin Pharmacother
ISSN: 1744-7666
Language: eng
Dates:
DateEvent
14 November 2018Published
29 October 2018Accepted
Publisher License: Publisher's own licence
PubMed ID: 30428279
Go to PubMed abstract
URI: https://openaccess.sgul.ac.uk/id/eprint/110413
Publisher's version: https://doi.org/10.1080/14656566.2018.1543402

Actions (login required)

Edit Item Edit Item